{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T12:08:57Z","timestamp":1794485337622,"version":"4.9.1"},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2018,5,21]],"date-time":"2018-05-21T00:00:00Z","timestamp":1526860800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Differ"],"published-print":{"date-parts":[[2018,11]]},"DOI":"10.1038\/s41418-018-0127-2","type":"journal-article","created":{"date-parts":[[2018,5,21]],"date-time":"2018-05-21T13:13:03Z","timestamp":1526908383000},"page":"2037-2049","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":170,"title":["Dopamine D2 receptor restricts astrocytic NLRP3 inflammasome activation via enhancing the interaction of \u03b2-arrestin2 and NLRP3"],"prefix":"10.1038","volume":"25","author":[{"given":"Jialei","family":"Zhu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhaoli","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaojuan","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongshuo","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingling","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianhua","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gang","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,5,21]]},"reference":[{"key":"127_CR1","doi-asserted-by":"crossref","first-page":"278","DOI":"10.3389\/fncel.2015.00278","volume":"9","author":"L Haim Ben","year":"2015","unstructured":"Ben Haim L, Carrillo-de Sauvage MA, Ceyzeriat K, Escartin C. Elusive roles for reactive astrocytes in neurodegenerative diseases. Front Cell Neurosci. 2015;9:278.","journal-title":"Front Cell Neurosci"},{"key":"127_CR2","doi-asserted-by":"publisher","first-page":"272","DOI":"10.3389\/fncel.2013.00272","volume":"7","author":"D Davila","year":"2013","unstructured":"Davila D, Thibault K, Fiacco TA, Agulhon C. Recent molecular approaches to understanding astrocyte function in vivo. Front Cell Neurosci. 2013;7:272.","journal-title":"Front Cell Neurosci"},{"key":"127_CR3","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/j.neuroscience.2015.12.044","volume":"316","author":"JA Cobb","year":"2016","unstructured":"Cobb JA, O\u2019Neill K, Milner J, Mahajan GJ, Lawrence TJ, May WL, et al. Density of GFAP-immunoreactive astrocytes is decreased in left hippocampi in major depressive disorder. Neuroscience. 2016;316:209\u201320.","journal-title":"Neuroscience"},{"key":"127_CR4","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1007\/s00011-015-0895-9","volume":"65","author":"XL Yang","year":"2016","unstructured":"Yang XL, Kim CK, Kim TJ, Sun J, Rim D, Kim YJ, et al. Anti-inflammatory effects of fimasartan via Akt, ERK, and NFkappaB pathways on astrocytes stimulated by hemolysate. Inflamm Res. 2016;65:115\u201323.","journal-title":"Inflamm Res"},{"key":"127_CR5","doi-asserted-by":"publisher","first-page":"14489","DOI":"10.1523\/JNEUROSCI.1256-12.2012","volume":"32","author":"ME Hamby","year":"2012","unstructured":"Hamby ME, Coppola G, Ao Y, Geschwind DH, Khakh BS, Sofroniew MV. Inflammatory mediators alter the astrocyte transcriptome and calcium signaling elicited by multiple G-protein-coupled receptors. J Neurosci. 2012;32:14489\u2013510.","journal-title":"J Neurosci"},{"key":"127_CR6","doi-asserted-by":"publisher","first-page":"155","DOI":"10.5625\/lar.2015.31.4.155","volume":"31","author":"JW Yun","year":"2015","unstructured":"Yun JW, Ahn JB, Kang BC. Modeling Parkinson\u2019s disease in the common marmoset (Callithrix jacchus): overview of models, methods, and animal care. Lab Anim Res. 2015;31:155\u201365.","journal-title":"Lab Anim Res"},{"key":"127_CR7","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1093\/jnen\/62.8.812","volume":"62","author":"F Mori","year":"2003","unstructured":"Mori F, Piao YS, Hayashi S, Fujiwara H, Hasegawa M, Yoshimoto M, et al. Alpha-synuclein accumulates in Purkinje cells in Lewy body disease but not in multiple system atrophy. J Neuropathol Exp Neurol. 2003;62:812\u20139.","journal-title":"J Neuropathol Exp Neurol"},{"key":"127_CR8","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1111\/jnc.13529","volume":"139","author":"E Valera","year":"2016","unstructured":"Valera E, Masliah E. Therapeutic approaches in Parkinson\u2019s disease and related disorders. J Neurochem. 2016;139:346\u201352.","journal-title":"J Neurochem"},{"key":"127_CR9","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-016-0527-5","volume":"13","author":"YF Dong","year":"2016","unstructured":"Dong YF, Chen ZZ, Zhao Z, Yang DD, Yan H, Ji J, et al. Potential role of microRNA-7 in the anti-neuroinflammation effects of nicorandil in astrocytes induced by oxygen-glucose deprivation. J Neuroinflamm. 2016;13:60.","journal-title":"J Neuroinflamm"},{"key":"127_CR10","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/j.dib.2016.02.018","volume":"7","author":"AN Shrivastava","year":"2016","unstructured":"Shrivastava AN, Redeker V, Fritz N, Pieri L, Almeida LG, Spolidoro M, et al. Data in support of the identification of neuronal and astrocyte proteins interacting with extracellularly applied oligomeric and fibrillar alpha-synuclein assemblies by mass spectrometry. Data Brief. 2016;7:221\u20138.","journal-title":"Data Brief"},{"key":"127_CR11","doi-asserted-by":"publisher","first-page":"476","DOI":"10.3389\/fncel.2015.00476","volume":"9","author":"D Brites","year":"2015","unstructured":"Brites D, Fernandes A. Neuroinflammation and depression: microglia activation, extracellular microvesicles and microRNA dysregulation. Front Cell Neurosci. 2015;9:476.","journal-title":"Front Cell Neurosci"},{"key":"127_CR12","first-page":"537","volume":"77","author":"O Komine","year":"2015","unstructured":"Komine O, Yamanaka K. Neuroinflammation in motor neuron disease. Nagoya J Med Sci. 2015;77:537\u201349.","journal-title":"Nagoya J Med Sci"},{"key":"127_CR13","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/s40035-015-0042-0","volume":"4","author":"Q Wang","year":"2015","unstructured":"Wang Q, Liu Y, Zhou J. Neuroinflammation in Parkinson\u2019s disease and its potential as therapeutic target. Transl Neurodegener. 2015;4:19.","journal-title":"Transl Neurodegener"},{"key":"127_CR14","first-page":"63","volume":"11","author":"L Song","year":"2017","unstructured":"Song L, Pei L, Yao S, Wu Y, Shang Y. NLRP3 inflammasome in neurological diseases, from functions to therapies. Front Cell Neurosci. 2017;11:63.","journal-title":"Front Cell Neurosci"},{"key":"127_CR15","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.lfs.2015.05.011","volume":"135","author":"F Shi","year":"2015","unstructured":"Shi F, Kouadir M, Yang Y. NALP3 inflammasome activation in protein misfolding diseases. Life Sci. 2015;135:9\u201314.","journal-title":"Life Sci"},{"key":"127_CR16","first-page":"15","volume":"8","author":"E Ozaki","year":"2015","unstructured":"Ozaki E, Campbell M, Doyle SL. Targeting the NLRP3 inflammasome in chronic inflammatory diseases: current perspectives. J Inflamm Res. 2015;8:15\u201327.","journal-title":"J Inflamm Res"},{"key":"127_CR17","doi-asserted-by":"publisher","first-page":"262","DOI":"10.3389\/fphar.2015.00262","volume":"6","author":"BZ Shao","year":"2015","unstructured":"Shao BZ, Xu ZQ, Han BZ, Su DF, Liu C. NLRP3 inflammasome and its inhibitors: a review. Front Pharmacol. 2015;6:262.","journal-title":"Front Pharmacol"},{"key":"127_CR18","doi-asserted-by":"publisher","first-page":"5589","DOI":"10.1111\/bph.12876","volume":"171","author":"SM Krishnan","year":"2014","unstructured":"Krishnan SM, Sobey CG, Latz E, Mansell A, Drummond GR. IL-1beta nd IL-18: inflammatory markers or mediators of hypertension? Br J Pharmacol. 2014;171:5589\u2013602.","journal-title":"Br J Pharmacol"},{"key":"127_CR19","doi-asserted-by":"publisher","first-page":"952375","DOI":"10.1155\/2013\/952375","volume":"2013","author":"SV More","year":"2013","unstructured":"More SV, Kumar H, Kim IS, Song SY, Choi DK. Cellular and molecular mediators of neuroinflammation in the pathogenesis of Parkinson\u2019s disease. Mediat Inflamm. 2013;2013:952375.","journal-title":"Mediat Inflamm"},{"key":"127_CR20","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1097\/nen.0b013e31812503e1","volume":"66","author":"RE Mrak","year":"2007","unstructured":"Mrak RE, Griffin WS. Common inflammatory mechanisms in Lewy body disease and Alzheimer disease. J Neuropathol Exp Neurol. 2007;66:683\u20136.","journal-title":"J Neuropathol Exp Neurol"},{"key":"127_CR21","doi-asserted-by":"publisher","first-page":"349","DOI":"10.14336\/AD.2015.0330","volume":"6","author":"C Rangel-Barajas","year":"2015","unstructured":"Rangel-Barajas C, Coronel I, Floran B. Dopamine receptors and neurodegeneration. Aging Dis. 2015;6:349\u201368.","journal-title":"Aging Dis"},{"key":"127_CR22","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1038\/nature11748","volume":"494","author":"W Shao","year":"2013","unstructured":"Shao W, Zhang SZ, Tang M, Zhang XH, Zhou Z, Yin YQ, et al. Suppression of neuroinflammation by astrocytic dopamine D2 receptors via alphaB-crystallin. Nature. 2013;494:90\u201394.","journal-title":"Nature"},{"key":"127_CR23","doi-asserted-by":"publisher","first-page":"3533","DOI":"10.1242\/jcs.175158","volume":"128","author":"CD Hanlon","year":"2015","unstructured":"Hanlon CD, Andrew DJ. Outside-in signaling--a brief review of GPCR signaling with a focus on the Drosophila GPCR family. J Cell Sci. 2015;128:3533\u201342.","journal-title":"J Cell Sci"},{"key":"127_CR24","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1038\/gene.2015.47","volume":"16","author":"D Sharma","year":"2015","unstructured":"Sharma D, Parameswaran N. Multifaceted role of beta-arrestins in inflammation and disease. Genes Immun. 2015;16:576.","journal-title":"Genes Immun"},{"key":"127_CR25","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.1038\/aps.2015.74","volume":"36","author":"YJ Gu","year":"2015","unstructured":"Gu YJ, Sun WY, Zhang S, Wu JJ, Wei W. The emerging roles of beta-arrestins in fibrotic diseases. Acta Pharmacol Sin. 2015;36:1277\u201387.","journal-title":"Acta Pharmacol Sin"},{"key":"127_CR26","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1007\/s12035-013-8469-8","volume":"48","author":"T Jiang","year":"2013","unstructured":"Jiang T, Yu JT, Tan MS, Zhu XC, Tan L. beta-Arrestins as potential therapeutic targets for Alzheimer\u2019s disease. Mol Neurobiol. 2013;48:812\u20138.","journal-title":"Mol Neurobiol"},{"key":"127_CR27","doi-asserted-by":"publisher","first-page":"1154","DOI":"10.1016\/j.immuni.2013.05.015","volume":"38","author":"Y Yan","year":"2013","unstructured":"Yan Y, Jiang W, Spinetti T, Tardivel A, Castillo R, Bourquin C, et al. Omega-3 fatty acids prevent inflammation and metabolic disorder through inhibition of NLRP3 inflammasome activation. Immunity. 2013;38:1154\u201363.","journal-title":"Immunity"},{"key":"127_CR28","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1016\/j.tem.2015.09.001","volume":"26","author":"A Srivastava","year":"2015","unstructured":"Srivastava A, Gupta B, Gupta C, Shukla AK. Emerging functional divergence of beta-arrestin isoforms in GPCR function. Trends Endocrinol Metab. 2015;26:628\u201342.","journal-title":"Trends Endocrinol Metab"},{"key":"127_CR29","doi-asserted-by":"publisher","first-page":"e0141637","DOI":"10.1371\/journal.pone.0141637","volume":"10","author":"SM Peterson","year":"2015","unstructured":"Peterson SM, Pack TF, Caron MG. Receptor, ligand and transducer contributions to dopamine D2 receptor functional selectivity. PLoS ONE. 2015;10:e0141637.","journal-title":"PLoS ONE"},{"key":"127_CR30","doi-asserted-by":"publisher","first-page":"2071","DOI":"10.1002\/jcp.25317","volume":"231","author":"PY Jean-Charles","year":"2016","unstructured":"Jean-Charles PY, Rajiv V, Shenoy SK. Ubiquitin-related roles of beta-arrestins in endocytic trafficking and signal transduction. J Cell Physiol. 2016;231:2071\u201380.","journal-title":"J Cell Physiol"},{"key":"127_CR31","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1016\/j.neuropharm.2013.10.013","volume":"77","author":"L Iacovelli","year":"2014","unstructured":"Iacovelli L, Felicioni M, Nistico R, Nicoletti F, De Blasi A. Selective regulation of recombinantly expressed mGlu7 metabotropic glutamate receptors by G protein-coupled receptor kinases and arrestins. Neuropharmacology. 2014;77:303\u201312.","journal-title":"Neuropharmacology"},{"key":"127_CR32","doi-asserted-by":"publisher","first-page":"1395","DOI":"10.1016\/S0024-3205(97)00685-1","volume":"61","author":"R Meli","year":"1997","unstructured":"Meli R, Raso GM, Gualillo O, Pacilio M, Di Carlo R. Prolactin modulation of nitric oxide and TNF-alpha production by peripheral neutrophils in rats. Life Sci. 1997;61:1395\u2013403.","journal-title":"Life Sci"},{"key":"127_CR33","first-page":"496759","volume":"2015","author":"JH Lu","year":"2015","unstructured":"Lu JH, Liu YQ, Deng QW, Peng YP, Qiu YH. Dopamine D2 receptor is involved in alleviation of type II collagen-induced arthritis in mice. Biomed Res Int. 2015;2015:496759.","journal-title":"Biomed Res Int"},{"key":"127_CR34","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/S0006-8993(03)03318-3","volume":"987","author":"BK Taylor","year":"2003","unstructured":"Taylor BK, Joshi C, Uppal H. Stimulation of dopamine D2 receptors in the nucleus accumbens inhibits inflammatory pain. Brain Res. 2003;987:135\u201343.","journal-title":"Brain Res"},{"key":"127_CR35","doi-asserted-by":"publisher","first-page":"e38745","DOI":"10.1371\/journal.pone.0038745","volume":"7","author":"Y Zhang","year":"2012","unstructured":"Zhang Y, Cuevas S, Asico LD, Escano C, Yang Y, Pascua AM, et al. Deficient dopamine D2 receptor function causes renal inflammation independently of high blood pressure. PLoS ONE. 2012;7:e38745.","journal-title":"PLoS ONE"},{"key":"127_CR36","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1016\/j.exer.2004.12.015","volume":"80","author":"UW Laengle","year":"2005","unstructured":"Laengle UW, Markstein R, Schneider V, Greiner B, Roman D. Effects of antiglaucoma drugs timolol and GLC756, a novel dopamine D2 agonist and D1 antagonist, on endotoxin-induced-uveitis in rats. Exp Eye Res. 2005;80:847\u201352.","journal-title":"Exp Eye Res"},{"key":"127_CR37","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.expneurol.2011.08.001","volume":"232","author":"K Tanaka","year":"2011","unstructured":"Tanaka K, Kanno T, Yanagisawa Y, Yasutake K, Hadano S, Yoshii F, et al. Bromocriptine methylate suppresses glial inflammation and moderates disease progression in a mouse model of amyotrophic lateral sclerosis. Exp Neurol. 2011;232:41\u201352.","journal-title":"Exp Neurol"},{"key":"127_CR38","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1007\/s12035-016-9717-5","volume":"54","author":"V Lieberknecht","year":"2017","unstructured":"Lieberknecht V, Junqueira SC, Cunha MP, Barbosa TA, de Souza LF, Coelho IS, et al. Pramipexole, a dopamine D2\/D3 receptor-preferring agonist, prevents experimental autoimmune encephalomyelitis development in mice. Mol Neurobiol. 2017;54:1033\u201345.","journal-title":"Mol Neurobiol"},{"key":"127_CR39","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1186\/1758-5996-6-104","volume":"6","author":"M Ezrokhi","year":"2014","unstructured":"Ezrokhi M, Luo S, Trubitsyna Y, Cincotta AH. Neuroendocrine and metabolic components of dopamine agonist amelioration of metabolic syndrome in SHR rats. Diabetol Metab Syndr. 2014;6:104.","journal-title":"Diabetol Metab Syndr"},{"key":"127_CR40","doi-asserted-by":"publisher","first-page":"2090","DOI":"10.1007\/s12035-016-9803-8","volume":"54","author":"AM Delattre","year":"2017","unstructured":"Delattre AM, Carabelli B, Mori MA, Kempe PG, Rizzo de Souza LE, Zanata SM, et al. Maternal Omega-3 supplement improves dopaminergic system in pre- and postnatal inflammation-induced neurotoxicity in Parkinson\u2019s disease model. Mol Neurobiol. 2017;54:2090\u2013106.","journal-title":"Mol Neurobiol"},{"key":"127_CR41","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1097\/WNR.0000000000000548","volume":"27","author":"L Cao","year":"2016","unstructured":"Cao L, Li D, Feng P, Li L, Xue GF, Li G, et al. A novel dual GLP-1 and GIP incretin receptor agonist is neuroprotective in a mouse model of Parkinson\u2019s disease by reducing chronic inflammation in the brain. Neuroreport. 2016;27:384\u201391.","journal-title":"Neuroreport"},{"key":"127_CR42","doi-asserted-by":"publisher","first-page":"5076740","DOI":"10.1155\/2016\/5076740","volume":"2016","author":"P Zhou","year":"2016","unstructured":"Zhou P, Weng R, Chen Z, Wang R, Zou J, Liu X, et al. TLR4 signaling in MPP(\u2009+\u2009)-induced activation of BV-2 cells. Neural Plast. 2016;2016:5076740.","journal-title":"Neural Plast"},{"key":"127_CR43","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.cell.2014.11.047","volume":"160","author":"Y Yan","year":"2015","unstructured":"Yan Y, Jiang W, Liu L, Wang X, Ding C, Tian Z, et al. Dopamine controls systemic inflammation through inhibition of NLRP3 inflammasome. Cell. 2015;160:62\u201373.","journal-title":"Cell"},{"key":"127_CR44","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1089\/jir.2009.0017","volume":"30","author":"R Xia","year":"2010","unstructured":"Xia R, Hu Z, Sun Y, Chen S, Gu M, Zhou Y, et al. Overexpression of beta-arrestin 2 in peripheral blood mononuclear cells of patients with cryptococcal meningitis. J Interferon Cytokine Res. 2010;30:155\u201362.","journal-title":"J Interferon Cytokine Res"},{"key":"127_CR45","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1172\/JCI200317265","volume":"112","author":"JK Walker","year":"2003","unstructured":"Walker JK, Fong AM, Lawson BL, Savov JD, Patel DD, Schwartz DA, et al. Beta-arrestin-2 regulates the development of allergic asthma. J Clin Invest. 2003;112:566\u201374.","journal-title":"J Clin Invest"},{"key":"127_CR46","doi-asserted-by":"publisher","first-page":"23075","DOI":"10.1074\/jbc.M114.591495","volume":"289","author":"H Li","year":"2014","unstructured":"Li H, Hu D, Fan H, Zhang Y, LeSage GD, Caudle Y, et al. Beta-arrestin 2 negatively regulates toll-like receptor 4 (TLR4)-triggered inflammatory signaling via targeting p38 MAPK and interleukin 10. J Biol Chem. 2014;289:23075\u201385.","journal-title":"J Biol Chem"},{"key":"127_CR47","doi-asserted-by":"publisher","first-page":"74ra23","DOI":"10.1126\/scitranslmed.3001564","volume":"3","author":"AK Lovgren","year":"2011","unstructured":"Lovgren AK, Kovacs JJ, Xie T, Potts EN, Li Y, Foster WM, et al. beta-arrestin deficiency protects against pulmonary fibrosis in mice and prevents fibroblast invasion of extracellular matrix. Sci Transl Med. 2011;3:74ra23.","journal-title":"Sci Transl Med"},{"key":"127_CR48","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1038\/ni1489","volume":"8","author":"Y Shi","year":"2007","unstructured":"Shi Y, Feng Y, Kang J, Liu C, Li Z, Li D, et al. Critical regulation of CD4\u2009+\u2009T cell survival and autoimmunity by beta-arrestin 1. Nat Immunol. 2007;8:817\u201324.","journal-title":"Nat Immunol"},{"key":"127_CR49","doi-asserted-by":"publisher","first-page":"e68351","DOI":"10.1371\/journal.pone.0068351","volume":"8","author":"K Watari","year":"2013","unstructured":"Watari K, Nakaya M, Nishida M, Kim KM, Kurose H. Beta-arrestin2 in infiltrated macrophages inhibits excessive inflammation after myocardial infarction. PLoS ONE. 2013;8:e68351.","journal-title":"PLoS ONE"},{"key":"127_CR50","doi-asserted-by":"publisher","first-page":"7395","DOI":"10.1073\/pnas.1221608110","volume":"110","author":"J Li","year":"2013","unstructured":"Li J, Wei B, Guo A, Liu C, Huang S, Du F, et al. Deficiency of beta-arrestin1 ameliorates collagen-induced arthritis with impaired TH17 cell differentiation. Proc Natl Acad Sci USA. 2013;110:7395\u2013400.","journal-title":"Proc Natl Acad Sci USA"},{"key":"127_CR51","doi-asserted-by":"publisher","first-page":"1312","DOI":"10.1172\/JCI36806","volume":"119","author":"RW Walters","year":"2009","unstructured":"Walters RW, Shukla AK, Kovacs JJ, Violin JD, DeWire SM, Lam CM, et al. beta-Arrestin1 mediates nicotinic acid-induced flushing, but not its antilipolytic effect, in mice. J Clin Invest. 2009;119:1312\u201321.","journal-title":"J Clin Invest"},{"key":"127_CR52","doi-asserted-by":"publisher","first-page":"1867","DOI":"10.4049\/jimmunol.1401989","volume":"194","author":"K Mao","year":"2015","unstructured":"Mao K, Chen S, Wang Y, Zeng Y, Ma Y, Hu Y, et al. beta-arrestin1 is critical for the full activation of NLRP3 and NLRC4 inflammasomes. J Immunol. 2015;194:1867\u201373.","journal-title":"J Immunol"},{"key":"127_CR53","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1038\/nature17198","volume":"531","author":"S Nuber","year":"2016","unstructured":"Nuber S, Zabel U, Lorenz K, Nuber A, Milligan G, Tobin AB, et al. Beta-Arrestin biosensors reveal a rapid, receptor-dependent activation\/deactivation cycle. Nature. 2016;531:661\u20134.","journal-title":"Nature"},{"key":"127_CR54","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.mcn.2006.09.008","volume":"34","author":"XN Zeng","year":"2007","unstructured":"Zeng XN, Sun XL, Gao L, Fan Y, Ding JH, Hu G. Aquaporin-4 deficiency down-regulates glutamate uptake and GLT-1 expression in astrocytes. Mol Cell Neurosci. 2007;34:34\u201339.","journal-title":"Mol Cell Neurosci"},{"issue":"9","key":"127_CR55","doi-asserted-by":"publisher","first-page":"pyw047","DOI":"10.1093\/ijnp\/pyw047","volume":"19","author":"Ming Lu","year":"2016","unstructured":"Lu M, Su C, Qiao C, Bian Y, Ding J, Hu G. Metformin prevents dopaminergic neuron death in MPTP\/P-induced mouse model of Parkinson\u2019s disease via autophagy and mitochondrial ROS clearance. Int J Neuropsychopharmacol 2016, 19: pii: pyw047.","journal-title":"International Journal of Neuropsychopharmacology"},{"key":"127_CR56","doi-asserted-by":"publisher","first-page":"8935","DOI":"10.1073\/pnas.92.19.8935","volume":"92","author":"H Sauer","year":"1995","unstructured":"Sauer H, Rosenblad C, Bjorklund A. Glial cell line-derived neurotrophic factor but not transforming growth factor beta 3 prevents delayed degeneration of nigral dopaminergic neurons following striatal 6-hydroxydopamine lesion. Proc Natl Acad Sci USA. 1995;92:8935\u20139.","journal-title":"Proc Natl Acad Sci USA"}],"container-title":["Cell Death & Differentiation"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/s41418-018-0127-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41418-018-0127-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41418-018-0127-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T21:11:55Z","timestamp":1684617115000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41418-018-0127-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5,21]]},"references-count":56,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2018,11]]}},"alternative-id":["127"],"URL":"https:\/\/doi.org\/10.1038\/s41418-018-0127-2","relation":{},"ISSN":["1350-9047","1476-5403"],"issn-type":[{"value":"1350-9047","type":"print"},{"value":"1476-5403","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,5,21]]},"assertion":[{"value":"30 November 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 March 2018","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 May 2018","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 May 2018","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}